Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,285.61
(
-0.05%
)
News Focus
News Focus
Post# of 257302
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Double_Bagel

Send PM Follow Ignore
Followers 14
Posts 898
Boards Moderated 0
Alias Born 03/07/2011

Double_Bagel

Re: DewDiligence post# 181019

Thursday, 08/07/2014 9:13:55 AM

Thursday, August 07, 2014 9:13:55 AM

Post# of 257302

ENTA—Today's announcement of the clinical advancement of EDP-239 (#msg-105063800) is probably the reason ENTA's CSO exercised options two days ago without selling the new shares.



I am not sure that I understand. Are you saying that this news was not expected soon and should cause the shares to rise quite a bit? The first milestone of $15 million is not due for quite a while, so there is no immediate benefit to the bottom line. Thanks.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today